Company intelligence / Profile preview
APA Advanced Technologies
Ramat Gan, Israel
- Ownership
- Private
- Development stage
- Other
01
Overview
APA Advanced Technologies is an Israeli biotechnology company founded in 1972 and based in Ramat Gan. The company specializes in the development of advanced drug delivery systems, particularly focusing on its proprietary fusogenic liposome platform. These specialized liposomes are designed to selectively fuse with tumor cell membranes, enabling targeted delivery of therapeutic agents and diagnostic imaging markers directly into the cytoplasm of cancer cells. APA Advanced Technologies' research and development efforts are led by prominent scientists, including Professor Avi Schroeder from the Technion, and are aimed at improving the efficacy and safety of cancer therapies and tumor imaging.
- Therapeutic areas
- Oncology
- Modalities
- LiposomeNanoparticleBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on APA Advanced Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on APA Advanced Technologies.